Middleton & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,588
| Closed | -$237K | – | 162 |
|
|
2024
Q3 | $237K | Hold |
3,588
| – | – | 0.03% | 146 |
|
|
2024
Q2 | $331K | Sell |
3,588
-200
| -5% | -$18.5K | 0.04% | 125 |
|
|
2024
Q1 | $362K | Sell |
3,788
-200
| -5% | -$19.1K | 0.04% | 134 |
|
|
2023
Q4 | $304K | Hold |
3,988
| – | – | 0.04% | 129 |
|
|
2023
Q3 | $276K | Hold |
3,988
| – | – | 0.04% | 128 |
|
|
2023
Q2 | $376K | Sell |
3,988
-1,732
| -30% | -$163K | 0.05% | 120 |
|
|
2023
Q1 | $473K | Hold |
5,720
| – | – | 0.07% | 107 |
|
|
2022
Q4 | $427K | Buy |
5,720
+2,485
| +77% | +$185K | 0.06% | 116 |
|
|
2022
Q3 | $267K | Hold |
3,235
| – | – | 0.04% | 133 |
|
|
2022
Q2 | $308K | Sell |
3,235
-100
| -3% | -$9.52K | 0.04% | 132 |
|
|
2022
Q1 | $393K | Sell |
3,335
-50
| -1% | -$5.89K | 0.04% | 133 |
|
|
2021
Q4 | $439K | Hold |
3,385
| – | – | 0.04% | 126 |
|
|
2021
Q3 | $383K | Buy |
+3,385
| New | +$383K | 0.04% | 129 |
|
|
2021
Q1 | – | Sell |
-3,660
| Closed | -$334K | – | 153 |
|
|
2020
Q4 | $334K | Buy |
+3,660
| New | +$334K | 0.04% | 127 |
|
|
2020
Q3 | – | Sell |
-4,106
| Closed | -$284K | – | 142 |
|
|
2020
Q2 | $284K | Sell |
4,106
-46
| -1% | -$3.18K | 0.04% | 130 |
|
|
2020
Q1 | $261K | Sell |
4,152
-87
| -2% | -$5.47K | 0.05% | 129 |
|
|
2019
Q4 | $330K | Buy |
4,239
+960
| +29% | +$74.7K | 0.05% | 122 |
|
|
2019
Q3 | $240K | Hold |
3,279
| – | – | 0.04% | 134 |
|
|
2019
Q2 | $202K | Hold |
3,279
| – | – | 0.03% | 138 |
|
|
2019
Q1 | $209K | Buy |
+3,279
| New | +$209K | 0.03% | 135 |
|